HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No 12, December 2019 – Precision Medicine for Brain Tumours       » First Alzheimer's drug to be approved in 17 years holds promise for treatment       » Tencent make medical information readily available to the public       » United States FDA approves first China-made cancer drug       » Value-Based Healthcare: A Paradigm Shift for Better Patient Outcomes       » Precision Agriculture for Future Nutritional Needs      
EDITOR'S LETTER
 

The ASEAN Economic Community — Challenges and Opportunities for Healthcare Companies

The idea of creating an integrated economic bloc amongst the members of the Association of Southeast Asian Nations (ASEAN) was first mooted in the early 2000s. Since then, the formation of the ASEAN Economic Community or AEC has become a reality, although at a slower pace than what its proponents had envisioned. Still, this is an important endeavour because its success, even partially, can help spur the region’s economic, social and political developments.

Healthcare is a priority sector that the various ASEAN governments have identified for region-wide integration. It is therefore an important part of the AEC. The AEC’s formation is expected to further accelerate the growth of the region’s healthcare industry. This will be driven by additional foreign direct investments, freer flow of trade, manpower and capital within ASEAN, as well as the growing affluence among ASEAN countries.

Within this context, I had the opportunity to approach individuals who are deeply involved in the healthcare business in Asia and ask them to share their thoughts. The formation of the AEC will no doubt impact the activities of their companies and organisations in different ways, and their views of this development could be of interests to others who are looking to the ASEAN’s healthcare markets.

This section opens with an article by Dr Derrick Tan, the director of AsiaPac Bio LLP, and who has been involved in the life sciences industry in Singapore and Asia since the late 1990s. Derrick provides an overview of ASEAN’s healthcare market potential and suggest how business can grow in the region through Singapore. The remaining articles cover related topics and will provide snapshots of the opportunities and challenges facing organisations in biopharmaceuticals, medical devices and healthcare services sectors in this new environment. Hopefully, this will pique your interest sufficiently to find out more, leading to future endeavours in the ASEAN healthcare markets.

Marvin Ng
Principal Consultant, DN Venture Partners LLP

Marvin is principal consultant at DN Venture Partners LLP (www.dn-venture.com), a Singapore-based business development consulting firm that helps private and public organisations in the life sciences industry expand their business activities into Asia and beyond. He is also the co-editor of the Singapore Biotech Guide and the Singapore Medtech Portal.
NEWS CRUNCH  
news Proteona awards grant to clinician-scientist for research in treatment selection of multiple myeloma
news Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
December:
Precision Medicine for Brain Tumours
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy